Showing 20 of 70 recruiting trials for “Autoimmune thrombocytopenia”
BCMA-CD19 CCAR T Cell Treatment of Refractory Immune Thrombocytopenia Associated with Autoimmune Diseases
An Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune Thrombocytopenia
Safety and Efficacy of PRG-1801 in Recurrent/Refractory Primary Immune Thrombocytopenia (ITP)
👨⚕️ Heng Mei, Ph.D&M.D, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology📍 2 sites📅 Started Aug 2024View details ↗
Anti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP)
👨⚕️ Lei Zhang, MD, Chinese Academy of Medical Science and Blood Disease Hospital📍 1 site📅 Started Aug 2024View details ↗
The Efficacy and Safety of HCQ Plus TPO-RA in ANA Positive ITP
TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination
👨⚕️ Tienan Zhu, M.D., Peking Union Medical College Hospital📍 1 site📅 Started Jun 2024View details ↗
A Study of Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITP
The Efficacy and Safety of HCQ Plus Pred in ANA Positive ITP
The Efficacy and Safety of HCQ Plus DEX in ANA Positive ITP
Efficacy and Safety of CAR-T Cells Therapy for Chronic or Refractory Primary Immune Thrombocytopenia (ITP)
👨⚕️ Sanbin Wang, Doctor, 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China📍 1 site📅 Started Feb 2024View details ↗
Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP)
👨⚕️ Lei Zhang, MD, Chinese Academy of Medical Science and Blood Disease Hospital📍 1 site📅 Started Dec 2023View details ↗
Biologic Characterization of Patients With ITP
RecruitingNCT06107582 ↗
Longitudinal Cohort of Pediatric Primary Immune Thrombocytopenia (ITP)
👨⚕️ Lei Zhang, MD, Chinese Academy of Medical Science and Blood Disease Hospital📍 1 site📅 Started Nov 2023View details ↗
Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia
Prednisone Plus IVIg vs. Prednisone for ITP During Pregnancy
👨⚕️ Xiaohui Zhang, Professor, Peking University Insititute of Hematology, Peking University People's Hospital📍 1 site📅 Started Oct 2023View details ↗
A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Immune Thrombocytopenia
👨⚕️ Lei Zhang, MD, Chinese Academy of Medical Science and Blood Disease Hospital📍 1 site📅 Started Aug 2023View details ↗
The Investigate Efficacy and Safety Evaluation of Bortezomib in Patients With Relapsed/Refractory Immune Thrombocytopenia
👨⚕️ Dong-Yeop Shin, MD, PhD, Seoul National University Hospital📍 4 sites📅 Started Jul 2023View details ↗
RecruitingNCT06757257 ↗
Special Drug Use-results Survey for Long-term Use (Fostamatinib)
Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune Thrombocytopenia
Two Regimens of IVIG in the Treatment of Newly Diagnosed ITP in Children
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →